Science for a better life

Investor News

1 - 10

11 - 20

21 - 30

31 - 40

41 - 50

April 27, 2019

After Annual Stockholders' Meeting votes to not ratify Board of Management's actions:

Bayer's Supervisory Board unanimously stands behind Board of Management

more

April 26, 2019

CEO Werner Baumann at the Annual Stockholders' Meeting of Bayer AG:

"We made great progress - both operationally and strategically"

more

April 25, 2019

First quarter of 2019:

Bayer: strong operational start to the year

more

March 27, 2019

Bayer statement on jury's decision in phase two of California glyphosate trial

more

March 25, 2019

Bayer reaches settlement to resolve Xarelto™ litigation

more

March 19, 2019

Bayer statement on jury's decision in phase one of California glyphosate trial

more

March 08, 2019

Not intended for U.S. and UK Media

Bayer submits European marketing authorization application for darolutamide

more

March 05, 2019

Not intended for U.S. and UK Media

Bayer submits darolutamide for marketing authorization in Japan

more

February 27, 2019

Fiscal 2018:

Bayer increases sales and earnings - leader in agriculture after acquisition

more

February 27, 2019

Not intended for U.S. and UK Media

Bayer completes rolling submission for darolutamide in U.S.

more

1 - 10

11 - 20

21 - 30

31 - 40

41 - 50

Previous News can be found in the Archive

Services

Current Event

October 30, 2019

Q3 2019 Investor Conference Call

Current Links

IR News Archive Overview

Download Acrobat Reader

Email Newsletter

Last updated: February 15, 2019